• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.69% Nasdaq Up0.44%

    Atossa Genetics, Inc. (ATOS)

    1.01 Up 0.05(5.21%) Jul 29, 4:00PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Atossa Genetics, Inc.
    2345 Eastlake Avenue East
    Suite 201
    Seattle, WA 98102
    United States - Map
    Phone: 206-588-0256
    Fax: 206-430-1288
    Website: http://www.atossagenetics.com

    Index Membership:N/A
    Industry:Diagnostic Substances
    Full Time Employees:27

    Business Summary 

    Atossa Genetics Inc. operates as a healthcare company that focuses on the development of a suite of laboratory services, medical devices, and therapeutics for breast cancer in the United States. The company markets nipple aspirate fluid (NAF) cytology tests and pharmacogenomics tests. Its medical devices include the ForeCYTE Breast Aspirator and the FullCYTE Breast Aspirator devices that are intended for the collection of NAF for cytological testing at a laboratory. The company is also involved in the development of other devices comprising intraductal microcatheters for the collection of ductal lavage fluid and for the potential administration of a targeted therapeutic, as well as various tools for potential use by breast surgeons. Atossa Genetics Inc. was founded in 2009 and is headquartered in Seattle, Washington.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Atossa Genetics, Inc.

    Key Executives 
    Dr. Steven C. Quay M.D., Ph.D., FCAP, 64
    Chairman, Chief Exec. Officer, Pres and Treasurer
    Mr. Kyle Guse Esq., CPA, 51
    Chief Financial Officer, Gen. Counsel and Sec.
    Dr. Shu-Chih Chen Ph.D., 53
    Chief Scientific Officer and Director
    Mr. Scott Youmans , 48
    Sr. VP of Operations
    Ms. Cindy Atha ,
    VP of Sales and Marketing
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders